The former president's party urges supporters to remain calm and go out to vote on May 29
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, told reporters that US trials and assessments would be complete for approval "sometime in early April."
Also read: Covid-19: US's race to vaccinate millions off to slow, messy start
"Several tens of millions of doses will have been manufactured... and therefore will be available for use if the data supports its approval," he said.
He did not allege that Britain rushed its decision and praised Britain's MHRA regulatory agency as "science-based."
"Therefore I am not raising any question as to the decision that they have made," he said.
"Having said that, the requirements of the decision process as we have built it here in the US is what I can really comment on."
Slaoui also voiced hope for approval in the first half of February of the Janssen vaccine by Johnson & Johnson, which in contrast to the initially approved vaccines comes in a single dose.
The former president's party urges supporters to remain calm and go out to vote on May 29
Gold jewellery shoppers in Dubai usually opt for a wait-and-watch approach when prices hit record peaks
The authority confirmed that the administrative closure order will continue as long as the reasons for it exist
Hamas strongly condemns prosecutor's bid to get arrest warrants against its leaders as Israel calls the move against PM a historical disgrace
E& UAE has played a vital role in achieving the country’s connectivity ambitions
107 asset and fund managers operating in ADGM, currently managing 137 funds
His admission to stealing from Trump Organization could chip away at his credibility as a star witness
General elections will be held in South Africa on May 29 to elect the National Assembly